Samlyn Capital’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Samlyn Capital's DGX Position: Q3 2026 in Review
Samlyn Capital opened a new position in Quest Diagnostics (DGX) in Q3 2026: 117,407 shares worth $27.4M. The stake represents 0.46% of the portfolio and ranks #57 among its holdings. This is a return to the name: Samlyn Capital previously reported a position in DGX as recently as Q2 2013.
Samlyn Capital first reported a position in DGX in Q2 2013 and has held it in 2 quarters since. The position peaked at $38.7M in Q2 2013. 1,109 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Samlyn Capital held 117,407 shares of Quest Diagnostics worth $27.4M as of Q3 2026.
- Quest Diagnostics was a new Samlyn Capital position in Q3 2026.
- Quest Diagnostics made up 0.46% of Samlyn Capital's portfolio in Q3 2026, its #57 holding.
- Samlyn Capital first reported a position in Quest Diagnostics in Q2 2013 and has held it in 2 quarters since.
- Samlyn Capital's Quest Diagnostics position peaked at $38.7M in Q2 2013.
- 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Samlyn Capital's 13F filing for Q3 2026, filed 16 Nov 2026.